Stay updated on Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety and efficacy evaluation of BI 695500 in patients with moderately to severely active rheumatoid arthritis.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:59.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as informed consent, health conditions, and prior treatments. This change provides more comprehensive information about the inclusion and exclusion criteria for the clinical trial.
    Difference
    31%
    Check dated 2024-05-22T20:57:14.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:01:41.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of BI 695500 in Rheumatoid Arthritis Clinical Trial page.